Literature DB >> 19744400

Advances in treatment of obstructive sleep apnea syndrome.

Nancy A Collop1.   

Abstract

The treatments for obstructive sleep apnea (OSA) described in this paper represent the latest information and data. Nasal continuous positive airway pressure, initially described in 1981, remains the cornerstone of therapy. Advances in mask interfaces, the use of humidification, the downloading of usage information, the development of pressure delivery modifications, and reductions in the size and noise of the machines have improved the devices over the past decade. Nevertheless, the basic premise of positive pressure delivery to splint the airway remains the primary driver of efficacy. Surgery for OSA, other than tracheostomy, has also been used for about the same period (uvulopalatopharyngoplasty was also initially described in 1981), but its efficacy has probably improved only marginally. The advances in surgical techniques have come through improved patient selection, minimally invasive techniques, and the performance of outcome studies. Surgery clearly remains a second-line or third-line therapy for moderate to severe OSA. Dental appliances were also introduced over two decades ago and clearly have become more mainstream in our treatment approach to OSA. Dental appliances are now considered a reasonable first-line therapy for mild OSA and perhaps even for some patients with moderate OSA. Custom-made appliances are clearly superior to those that cannot be adjusted, and in the hands of an experienced dentist or similarly trained expert, they are moderately successful for most patients. Among the newer therapies, transnasal insufflation and nasal expiratory resistance clearly have promise, again for patients with mild to moderate OSA. Further study may determine who will benefit from such modalities. No medications have been shown to have clinically significant efficacy, and drug treatment remains adjunctive.

Entities:  

Year:  2009        PMID: 19744400     DOI: 10.1007/s11940-009-0038-0

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  47 in total

1.  Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.

Authors:  A I Pack; J E Black; J R Schwartz; J K Matheson
Journal:  Am J Respir Crit Care Med       Date:  2001-11-01       Impact factor: 21.405

2.  Treatment adherence and outcomes in flexible vs standard continuous positive airway pressure therapy.

Authors:  Mark S Aloia; Michael Stanchina; J Todd Arnedt; Atul Malhotra; Richard P Millman
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

Review 3.  Effects and side-effects of surgery for snoring and obstructive sleep apnea--a systematic review.

Authors:  Karl A Franklin; Heidi Anttila; Susanna Axelsson; Thorarinn Gislason; Paula Maasilta; Kurt I Myhre; Nina Rehnqvist
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

4.  Eszopiclone improves overnight polysomnography and continuous positive airway pressure titration: a prospective, randomized, placebo-controlled trial.

Authors:  Christopher J Lettieri; Timothy N Quast; Arn H Eliasson; Teotimo Andrada
Journal:  Sleep       Date:  2008-09       Impact factor: 5.849

5.  Palate implants for obstructive sleep apnea: multi-institution, randomized, placebo-controlled study.

Authors:  David L Steward; Todd C Huntley; B Tucker Woodson; Victoria Surdulescu
Journal:  Otolaryngol Head Neck Surg       Date:  2008-10       Impact factor: 3.497

6.  Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids.

Authors:  Shahrokh Javaheri; Athar Malik; Jason Smith; Eugene Chung
Journal:  J Clin Sleep Med       Date:  2008-08-15       Impact factor: 4.062

7.  Comparison of sedation with midazolam and ketamine: effects on airway muscle activity.

Authors:  G B Drummond
Journal:  Br J Anaesth       Date:  1996-05       Impact factor: 9.166

8.  A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome.

Authors:  Russell Rosenberg; James M Roach; Martin Scharf; David A Amato
Journal:  Sleep Med       Date:  2007-05-18       Impact factor: 3.492

9.  Recurrence of sleep apnea without concomitant weight increase 7.5 years after weight reduction surgery.

Authors:  G Pillar; R Peled; P Lavie
Journal:  Chest       Date:  1994-12       Impact factor: 9.410

10.  A randomized trial of temperature-controlled radiofrequency, continuous positive airway pressure, and placebo for obstructive sleep apnea syndrome.

Authors:  B Tucker Woodson; David L Steward; Edward M Weaver; Shahrokh Javaheri
Journal:  Otolaryngol Head Neck Surg       Date:  2003-06       Impact factor: 5.591

View more
  3 in total

Review 1.  Bariatric Surgery or Non-Surgical Weight Loss for Obstructive Sleep Apnoea? A Systematic Review and Comparison of Meta-analyses.

Authors:  Hutan Ashrafian; Tania Toma; Simon P Rowland; Leanne Harling; Alan Tan; Evangelos Efthimiou; Ara Darzi; Thanos Athanasiou
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

Review 2.  Surgical therapy of obstructive sleep apnea: a review.

Authors:  Bettina Carvalho; Jennifer Hsia; Robson Capasso
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

3.  Efficacy of a mandibular advancement intraoral appliance (MOA) for the treatment of obstructive sleep apnea syndrome (OSAS) in pediatric patients: A pilot-study.

Authors:  G Modesti-Vedolin; C Chies; S Chaves-Fagondes; E Piza-Pelizzer; M Lima-Grossi
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.